Filing Flows › Comparisons › ALMR vs HBIO
Alamar Biosciences vs Harvard Bioscience: ALMR and HBIO compared
Alamar Biosciences is the larger company: $33.5M of revenue in its latest quarter (Q3 2026) against $22.7M for Harvard Bioscience (Q2 2026). Alamar Biosciences is growing faster (+68% against +11% a year earlier). Harvard Bioscience is more profitable, with an operating margin of -4.3% against -45.1%.
Where the money goes: ALMR and HBIO
Alamar Biosciences (ALMR) · Q3 2026
Alamar Biosciences, Q3 2026: revenue $33.5M (+68% year over year), operating margin -45.1%, net loss $13.3M, operating cash flow −$14.7M. The chart follows the revenue to costs, profit and cash.
Harvard Bioscience (HBIO) · Q2 2026
Harvard Bioscience, Q2 2026: revenue $22.7M (+11% year over year), operating margin -4.3%, net loss $2.9M, operating cash flow $325K. The chart follows the revenue to costs, profit and cash.
| Alamar Biosciences (ALMR) | Harvard Bioscience (HBIO) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $33.5M | $22.7M |
| Revenue growth, Y/Y | +68% | +11% |
| Operating margin | -45.1% | -4.3% |
| Net earnings | −$13.3M | −$2.9M |
| Net margin | -39.8% | -12.8% |
| Operating cash flow | −$14.7M | $325K |
Where the revenue comes from
Alamar Biosciences
- Product: $26.3M (78%)
- Service Other: $7.2M (22%)
Harvard Bioscience
- Instruments, Equipment, Software, and Accessories: $20.3M (89%)
- Service, Maintenance, and Warranty Contracts: $2.4M (11%)
Questions
Which is bigger, Alamar Biosciences or Harvard Bioscience?
Alamar Biosciences is the larger company: $33.5M of revenue in its latest quarter (Q3 2026) against $22.7M for Harvard Bioscience (Q2 2026).
Is Alamar Biosciences or Harvard Bioscience growing faster?
Alamar Biosciences is growing faster (+68% against +11% a year earlier).
Which is more profitable, Alamar Biosciences or Harvard Bioscience?
Harvard Bioscience is more profitable, with an operating margin of -4.3% against -45.1%.
More: Alamar Biosciences earnings · how Alamar Biosciences makes money · Harvard Bioscience earnings · how Harvard Bioscience makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Aug 11, 2026). Fiscal quarters can end on different dates. Not investment advice.